Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Passage Bio Inc (NQ: PASG ) 1.010 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Jun 17, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open 1.010 Bid (Size) 1.000 (32) Ask (Size) 1.030 (16) Prev. Close 1.010 Today's Range 1.010 - 1.010 52wk Range 0.5751 - 1.790 Shares Outstanding 61,640,596 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Passage Bio to Present at Goldman Sachs 45th Annual Global Healthcare Conference June 05, 2024 From Passage Bio Via GlobeNewswire PASG Stock Earnings: Passage Bio Beats EPS for Q1 2024 May 14, 2024 PASG stock results show that Passage Bio beat analyst estimates for earnings per share the first quarter of 2024. Via InvestorPlace Performance YTD +12.09% +12.09% 1 Month -22.90% -22.90% 3 Month -30.82% -30.82% 6 Month +39.89% +39.89% 1 Year +8.98% +8.98% More News Read More Passage Bio Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights May 14, 2024 From Passage Bio Via GlobeNewswire Passage Bio to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit April 22, 2024 From Passage Bio Via GlobeNewswire Recap: Passage Bio Q3 Earnings November 13, 2023 Via Benzinga PASG Stock Earnings: Passage Bio Beats EPS for Q4 2023 March 06, 2024 Via InvestorPlace Passage Bio Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Recent Business Highlights March 04, 2024 From Passage Bio Via GlobeNewswire Passage Bio to Participate in Upcoming Investor Conferences February 27, 2024 From Passage Bio Via GlobeNewswire 7 Analyst-Backed Stocks With Promising 10-Bagger Potential February 01, 2024 Via InvestorPlace Passage Bio to Present at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference January 31, 2024 From Passage Bio Via GlobeNewswire 12 Health Care Stocks Moving In Friday's Pre-Market Session January 26, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's After-Market Session January 22, 2024 Via Benzinga 12 Health Care Stocks Moving In Wednesday's After-Market Session January 17, 2024 Via Benzinga 7 Nano-Cap Stocks That Pack a Serious Punch for Their Weight December 25, 2023 Via InvestorPlace 12 Health Care Stocks Moving In Thursday's Pre-Market Session December 21, 2023 Via Benzinga Why BlackBerry Shares Are Trading Lower By Over 5%; Here Are 20 Stocks Moving Premarket December 21, 2023 Via Benzinga Neurology-Focused Passage Bio Reveals Initial Data From Dementia Study, Outlines Strategic Priorities December 20, 2023 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session December 20, 2023 Via Benzinga Passage Bio Announces Promising Initial Data From Phase 1/2 Clinical Trial of PBFT02 in FTD-GRN and Updated Strategic Priorities December 20, 2023 From Passage Bio Via GlobeNewswire Passage Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4) November 17, 2023 From Passage Bio Via GlobeNewswire Monday.Com To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Tuesday November 14, 2023 Via Benzinga Passage Bio Reports Third Quarter 2023 Financial Results and Provides Recent Business Highlights November 13, 2023 From Passage Bio Via GlobeNewswire 12 Health Care Stocks Moving In Friday's After-Market Session November 03, 2023 Via Benzinga Passage Bio to Present at Guggenheim’s 5th Annual Inflammation, Neurology & Immunology Conference October 30, 2023 From Passage Bio Via GlobeNewswire Passage Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) October 20, 2023 From Passage Bio Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
